ホーム › 結腸癌 › カリフォルニア州 › Los Angeles
Los Angeles、CAにおける結腸癌の臨床試験
Los Angelesとその周辺地域（約30マイル以内）の拠点で、結腸癌に関する16件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
被験者募集中第3相
- Los Angeles Hematology Oncology Medical Group ( Site 0084), Los Angeles
A Study of PHN-012 in Patients With Advanced Solid Tumors
被験者募集中第1相
- PHN-012-001 Site, Los Angeles
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- University of California Los Angeles Health, Los Angeles
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
被験者募集中
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Kaiser Permanente West Los Angeles, Los Angeles
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
被験者募集中第2/3相
- Keck Medicine of USC Koreatown, Los Angeles
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- 他3件
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
被験者募集中第1相
- UCLA, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
EXoPERT EMERALD Clinical Study
被験者募集中観察研究健康なボランティア歓迎
- City of Hope Duarte Cancer Center, Los Angeles
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
被験者募集中第1相
- Cedars-Sinai Medical Center, Los Angeles
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
被験者募集中第1相
- University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- UCLA Medical Center, Los Angeles
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
被験者募集中観察研究
- Cedars-Sinai Medical Center, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
被験者募集中
- Oncology Institute for Hope and Innovation, Los Angeles
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
被験者募集中
- Cedars-Sinai Medical Center, Los Angeles
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
被験者募集中第3相
- GSK Investigational Site, Los Angeles
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
被験者募集中第1/2相
- UCLA Medical Center, Los Angeles
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
被験者募集中第2相
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
他の都市における結腸癌の試験
- Boston, MA22件の研究
- New York City, NY22件の研究
- Houston, TX20件の研究
- Nashville, TN16件の研究
- St. Louis, MO15件の研究
- Arlington, VA15件の研究
- Chicago, IL14件の研究
- San Antonio, TX14件の研究
- Baldwin Park, CA14件の研究
- Baltimore, MD13件の研究
- Tampa, FL13件の研究
- Washington, DC12件の研究
Los Angelesにおける他の研究
- 非小細胞肺癌87件の研究
- がん（全種類）74件の研究
- 乳がん73件の研究
- 前立腺がん61件の研究
- 大腸癌59件の研究
- 転移性癌57件の研究
- 卵巣がん50件の研究
- 肺がん45件の研究
- 頭頸部扁平上皮癌42件の研究
- 膵臓がん35件の研究
- 子宮内膜がん34件の研究
- 悪性黒色腫34件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。